ATE27772T1 - Pharmazeutische zusammensetzungen zur bekaempfung des widerstands von bakterien enthaltenden anaerobien. - Google Patents

Pharmazeutische zusammensetzungen zur bekaempfung des widerstands von bakterien enthaltenden anaerobien.

Info

Publication number
ATE27772T1
ATE27772T1 AT83109144T AT83109144T ATE27772T1 AT E27772 T1 ATE27772 T1 AT E27772T1 AT 83109144 T AT83109144 T AT 83109144T AT 83109144 T AT83109144 T AT 83109144T AT E27772 T1 ATE27772 T1 AT E27772T1
Authority
AT
Austria
Prior art keywords
anaerobia
combat
bacterial
resistance
pharmaceutical compositions
Prior art date
Application number
AT83109144T
Other languages
English (en)
Inventor
Maxwell Gordon
Irwin J Pachter
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Application granted granted Critical
Publication of ATE27772T1 publication Critical patent/ATE27772T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT83109144T 1983-09-15 1983-09-15 Pharmazeutische zusammensetzungen zur bekaempfung des widerstands von bakterien enthaltenden anaerobien. ATE27772T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP83109144A EP0134302B1 (de) 1983-09-15 1983-09-15 Pharmazeutische Zusammensetzungen zur Bekämpfung des Widerstands von Bakterien enthaltenden Anaerobien

Publications (1)

Publication Number Publication Date
ATE27772T1 true ATE27772T1 (de) 1987-07-15

Family

ID=8190683

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83109144T ATE27772T1 (de) 1983-09-15 1983-09-15 Pharmazeutische zusammensetzungen zur bekaempfung des widerstands von bakterien enthaltenden anaerobien.

Country Status (3)

Country Link
EP (1) EP0134302B1 (de)
AT (1) ATE27772T1 (de)
DE (1) DE3372068D1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT392903B (de) * 1987-10-08 1991-07-10 Hoechst Ag Pharmazeutische zubereitung enthaltend ein cephalosporin und ein penemantibiotikum

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234579A (en) * 1977-06-07 1980-11-18 Pfizer Inc. Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
PH16771A (en) * 1978-04-19 1984-02-22 Ciba Geigy Ag Synergistic mixtures of cepsulodin sodium and an aminoglycoside
IL61880A (en) * 1980-01-21 1984-11-30 Bristol Myers Co 2beta-chloromethyl-2alpha-methylpenam-3alpha-carboxylic acid sulfone derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DE3372068D1 (en) 1987-07-23
EP0134302A1 (de) 1985-03-20
EP0134302B1 (de) 1987-06-16

Similar Documents

Publication Publication Date Title
DK552684D0 (da) Desulfatohirudiner samt deres fremstilling og anvendelse
DE3579113D1 (de) Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.
DE3889350D1 (de) Kautschukzusammensetzung und ihre Verwendung bei der Herstellung von Packungen und Schläuchen.
MA21182A1 (fr) Ester 2,3,5,6-tetrafluorobenzylique d'acide (+) 1r-trans-2,2-dimeghyl-3-(2,2 dichlorovinyl) -cyclopropane-carboxylique, son procede de preparation et composition insecticide le contenant.
ATE68697T1 (de) Verwendung von azolylmethyloxiranen zur bekaempfung von viralen erkrankungen.
DE3880047D1 (de) Zusammensetzung eines zusatzes.
IT8023051A0 (it) Particelle sferiche di carbone attivato adatte all'impiego in composizioni farmaceutiche controle intossicazioni.
DE3684819D1 (de) Choline-ester-salze enthaltende pharmazeutische zusammensetzung zur erhoehung der absorption der magen-darmwege.
ES2030579T3 (es) Tratamiento de penetracion para substratos porosos.
ATE35827T1 (de) Menschliches lymphotoxin und seine derivate, verfahren zu seiner herstellung und dasselbe enthaltende pharmazeutische zusammensetzungen.
DE3850366D1 (de) Ternäre Foto-Initiatorzusammensetzung zur Additionspolymerisation.
DE3781488D1 (de) Pharmazeutische zusammensetzung, enthaltend 2',3'-dideoxycytidin-2'-en(2',3'-dideoxy-2',3'-didehydrocytidin) zur behandlung von mit retrovirus infizierten patienten.
DE3579989D1 (de) Mischung von interferon und cyclaradin.
ES2025663T3 (es) Composiciones inoculantes para plantas.
UA26442C2 (uk) Фармкомпозиція для профілактики і лікуваhhя захворюваhь, пов'язаhих з порушеhhям обміhу речовиh
IT7828410A0 (it) Procedimento per la modificazione microbiologica del legno duro per azione di microorganismi.
DE3886371D1 (de) Herstellung des hblv-virus in der hsb-2 zell-linie.
BE884379A (fr) Nouvelles alcoyloximes substituees derivees de l'acide 7-(2-amino 4-thiazolyl) acetamido cephalosporanique, preparation, application et compositions les renfermant
DE3767069D1 (de) Antivirales mittel zur hemmung des wachstums vom aids-syndrom-virus.
DE3372068D1 (en) Pharmaceutical compositions for treating resistant bacteria including anaerobes
DE68906167D1 (de) Zusammensetzung zur erkennung von paradontalen krankheiten.
FI872363A7 (fi) Bakteriosiinit ja niitä sisältävät koostumukset virusinfektioiden detektioon ja hoitoon.
DE3684756D1 (de) Durch (omega-amino)-alkanolgruppen substituierte aromatische derivate mit antimikrobenwirkung und diese enthaltende zusammensetzungen.
NO166225C (no) Fluorborsyresalt av n-tridecyl-2,6-dimetylmorfolin, fungicid og trebeskyttelsesmiddel inneholdende dette, samt anvendelse derav.
ES2110515T3 (es) Purificacion del factor xiii.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee